Towards new boron carriers for boron neutron capture therapy: metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates

Bioorg Med Chem. 2013 Mar 1;21(5):1136-42. doi: 10.1016/j.bmc.2012.12.039. Epub 2013 Jan 5.

Abstract

A method for the synthesis of cholesterol-metallacarborane conjugates bearing cobalt, iron and chromium was developed. Effective incorporation of the cholesterol conjugate bearing cobalt into liposome membrane was revealed. Using the metallacarborane-encrusted liposomes as boron delivery system in vivo biodistribution experiments in tumor-bearing mice, high accumulation and selective delivery of boron into tumor tissues was observed. The results demonstrate that the cholesterol-metallacarborane conjugates can be considered as a potential candidate for boron delivery vehicle in BNCT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Boron / chemistry*
  • Boron Neutron Capture Therapy
  • Cell Line, Tumor
  • Cholesterol / chemistry*
  • Chromium / chemistry*
  • Cobalt / chemistry*
  • Colonic Neoplasms / radiotherapy
  • Drug Carriers / chemistry
  • Drug Carriers / metabolism*
  • Female
  • Iron / chemistry*
  • Liposomes / chemistry
  • Liposomes / metabolism
  • Mice
  • Tissue Distribution

Substances

  • Drug Carriers
  • Liposomes
  • Chromium
  • Cobalt
  • Cholesterol
  • Iron
  • Boron